Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium

REtrospective, obserVational Study to Describe the Treatment Patterns and Outcomes of Epidermal Growth Factor Receptor Mutant (EGFRm) Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Patients in Belgium

This is a retrospective, observational, multicentre study to evaluate treatment patterns and outcomes of patients diagnosed with locally advanced or metastatic EGFRm NSCLC in Belgium

Inclusion Criteria:

• Male or female, aged at least 18 years
• Pathologically confirmed NSCLC
• Tumour harbours a mutation of EGFR
• Diagnosis (radiologically or pathologically confirmed) of locally advanced or metastatic NSCLC, not amenable to curative surgery or chemoradiotherapy between 01 September 2015 and 31 December 2017

Exclusion Criteria:

• No follow-up data available after diagnosis of locally advanced or metastatic EGFRm NSCLC
• Patients who objected to participation to the study